Ductal Carcinoma In Situ and Breast Cancer Overdiagnosis

Abstract

The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I 5 Immediate Family Member, Inst 5 My Institution. Relationships may not relate to the subject matter of this manuscript.

Reply to I. Jatoi

“…We thank Dr Jatoi 1 for highlighting additional areas of controversy regarding ductal carcinoma in situ (DCIS) in response to our article. 2 We agree that improved understanding of DCIS natural history is needed to determine the impact of its detection and treatment on invasive breast cancer (IBC) development and mortality.…”